Gene · 2203
Papers2,174
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,174
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multilevel Heterogeneity of Colorectal Cancer Liver Metastasis. | Cancers (Basel) | 2023 | 38201487 | PubTator, text mining | PubMed |
| Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | 38201450 | PubTator, text mining | PubMed |
| Hitting the Sweet Spot: How Glucose Metabolism Is Orchestrated in Space and Time by Phosphofructokinase-1. | Cancers (Basel) | 2023 | 38201444 | PubTator, text mining | PubMed |
| Ubiquitin signaling in pancreatic ductal adenocarcinoma. | Front Mol Biosci | 2023 | 38174069 | PubTator, text mining | PubMed |
| Correction: Fructose‑bisphosphatase1 (FBP1) alleviates experimental osteoarthritis by regulating Protein crumbs homolog 3 (CRB3). | Arthritis Res Ther | 2023 | 38155346 | PubTator, text mining | PubMed |
| Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders. | Pharmaceuticals (Basel) | 2023 | 38139841 | PubTator, text mining | PubMed |
| The Mechanism of Ubiquitination or Deubiquitination Modifications in Regulating Solid Tumor Radiosensitivity. | Biomedicines | 2023 | 38137461 | PubTator, text mining | PubMed |
| Research progress on the mechanism of glycolysis in ovarian cancer. | Front Immunol | 2023 | 38090580 | PubTator, text mining | PubMed |
| Unraveling the Sweet Secrets of HCC: Glucometabolic Rewiring in Hepatocellular Carcinoma. | Technol Cancer Res Treat | 2023 | 38083797 | PubTator, text mining | PubMed |
| Exploring the Prognostic Significance and Immunotherapeutic Potential of Single-Cell Sequencing-Identified Long Noncoding RNA (LncRNA) in Patients With Non-small Cell Lung Cancer. | Cureus | 2023 | 38074028 | PubTator, text mining | PubMed |
| Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma. | Eur J Med Res | 2023 | 38057871 | PubTator, text mining | PubMed |
| The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease. | Epigenetics Chromatin | 2023 | 38057834 | PubTator, text mining | PubMed |
| Fructose-bisphosphatase1 (FBP1) alleviates experimental osteoarthritis by regulating Protein crumbs homolog 3 (CRB3). | Arthritis Res Ther | 2023 | 38049890 | PubTator, text mining | PubMed |
| Lymphoid-specific helicase inhibits cervical cancer cells ferroptosis by promoting Nrf2 expression. | PeerJ | 2023 | 38047020 | PubTator, text mining | PubMed |
| Combined score of Y chromosome loss and T-cell infiltration improves UICC based stratification of esophageal adenocarcinoma. | Front Oncol | 2023 | 38045001 | PubTator, text mining | PubMed |
| Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes. | Diabetol Metab Syndr | 2023 | 38044448 | PubTator, text mining | PubMed |
| Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis. | J Clin Invest | 2023 | 38038136 | PubTator, text mining | PubMed |
| Methylmalonyl Coenzyme A (CoA) Epimerase Deficiency, an Ultra-Rare Cause of Isolated Methylmalonic Aciduria With Predominant Neurological Features. | Cureus | 2023 | 38034150 | PubTator, text mining | PubMed |
| Potential therapies targeting nuclear metabolic regulation in cancer. | MedComm (2020) | 2023 | 38034101 | PubTator, text mining | PubMed |
| Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome. | Front Endocrinol (Lausanne) | 2023 | 38034016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2203/papers?page=9